Previously, the lowest dose of Wegovy, 25 milligrams, was listed as in short supply. Since early 2022, several doses of semaglutide — the active ingredient in Wegovy and Ozempic — had been on the FDA’s shortage list.
Novo Nordisk confirmed that all doses of Wegovy and Ozempic are being regularly shipped to wholesalers, attributing the progress to investments in manufacturing capacity and ongoing communication with the FDA, CNBC reported Oct. 30. However, the company told the news outlet patients might still face delays in filling prescriptions at specific pharmacies.
The FDA update follows Novo Nordisk’s recent request to the agency to prevent compounding pharmacies from producing unapproved versions of the medications.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
